Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

J Hepatol. 2001 Sep;35(3):421-30. doi: 10.1016/s0168-8278(01)00130-1.

Authors

J Bruix¹, M Sherman, J M Llovet, M Beaugrand, R Lencioni, A K Burroughs, E Christensen, L Pagliaro, M Colombo, J Rodés; EASL Panel of Experts on HCC

Affiliation

¹ Liver Unit, Digestive Disease Institute, Hospital Clinic, IDIBAPS, Barcelona, Catalonia, Spain. jbruix@clinic.ub.es

PMID: 11592607
DOI: 10.1016/s0168-8278(01)00130-1

No abstract available

MeSH terms

Carcinoma, Hepatocellular / epidemiology
Carcinoma, Hepatocellular / etiology
Carcinoma, Hepatocellular / therapy*
Humans
Incidence
Liver Neoplasms / epidemiology
Liver Neoplasms / etiology
Liver Neoplasms / therapy*
Prognosis
Risk Factors